Skip to main content

Find Clinical Trials

Home
Conditions
Thrombocytosis

Clinical trial condition

Thrombocytosis

Explore clinical trials studying Thrombocytosis. Study availability and eligibility vary by location and protocol.

177 public trials 30 recruiting studies

Refine in advanced search Browse all conditions

Thrombocytosis trial results

Completed

Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.

NCT03869476

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
Locations: Chu Angers Angers, France

CHRU de Brest - Hôpital Morvan Brest, France

View Trial Details

Completed

Pegasys® in Patients With Myeloproliferative Diseases

NCT00452023

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients

NCT04243122

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +22 more
Locations: The Ottawa Hospital Ottawa, Ontario, Canada

View Trial Details

Completed

Ultrasound Examination for Spleen Volume Evaluation in Myeloproliferative Neoplasms

NCT06371573

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations: Federico II University Naples, Italy

View Trial Details

Completed

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant

NCT01588015

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +198 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Myeloproliferative Neoplasms: an In-depth Case-control Study

NCT01831635

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations: University Hospitals Southampton NHS Foundation Trust Southampton, England, United Kingdom

Belfast Health And Social Care Trust Belfast, Northern Ireland, United Kingdom

Queen's University Belfast Belfast, Northern Ireland, United Kingdom

View Trial Details

Completed

Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms

NCT01816256

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +16 more
Locations: Sunnybrook Health Sciences Centre Toronto, Ontario, Canada

Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Completed

CALR Exon 9 Mutant Peptide Vaccine to Patients With CALR-mutant Myeloproliferative Neoplasms

NCT03566446

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +10 more
Locations: Herlev Hospital Herlev, Capital Region, Denmark

View Trial Details

Completed

Dual Vaccine Trial in Myeloproliferative Neoplasms

NCT04051307

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations: Herlev Hospital Herlev, Capital Region, Denmark

National Center for Cancer Immune Therapy (CCIT-DK) Herlev, Denmark

View Trial Details

Completed

Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia

NCT02124746

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations: Scottsdale, Arizona, United States

Orange, California, United States

Stanford, California, United States

Whittier, California, United States

View all 22 locations

View Trial Details